Abstract: The positive electrode active material is capable of reducing positive electrode resistance, exhibiting better output characteristics, and having high mechanical strength when the positive electrode active material is used in a lithium ion secondary battery. Secondary particles have a d50 of 3.0 to 7.0 ?m, a BET specific surface area of 2.0 to 5.0 m2/g, a tap density of 1.0 to 2.0 g/cm3, and an oil absorption amount of 30 to 60 ml/100 g. In each of a plurality of primary particles having a primary particle size of 0.1 to 1.0 ?m, a coefficient of variation of the concentration of an additive element M is 1.5 or less. The volume of a linking section between the primary particles per primary particle, obtained from the total volume of the linking section and the number of primary particles constituting the secondary particles, is 5×105 to 9×107 nm3.

Abstract: A positive electrode active material includes lithium transition metal-containing composite oxide particles containing an additive element M1 and includes a coating layer formed of a metal composite oxide of Li and a metal element M2 on a part of a surface of the particles. The particles have a d50 of 3.0 to 7.0 ?m, a BET specific surface area of 2.0 to 5.0 m2/g, a tap density of 1.0 to 2.0 g/cm3, and an oil absorption amount of 30 to 60 ml/100 g. For each of a plurality of primary particles having a primary particle size within a range of 0.1 to 1.0 ?m among the primary particles, a coefficient of variation of the concentration of M1 is 1.5 or less, and the amount of M2 is 0.1 to 1.5 atom % with respect to the total number of atoms of Ni, Mn, and Co contained in the composite oxide particles.

Abstract: To provide a positive electrode active material capable of further reducing positive electrode resistance and exhibiting better output characteristics. A positive electrode active material includes a coating layer formed of a metal composite oxide of Li and one or more metal elements selected from Al, Ti, Zr, Nb, Mo, and W on at least a part of a surface of lithium transition metal-containing composite oxide particles, and has d50 of 3.0 to 7.0 ?m, a BET specific surface area of 2.0 to 5.0 m2/g, a tap density of 1.0 to 2.0 g/cm3, and an oil absorption amount of 30 to 60 ml/100 g, in which the amount of metal elements other than Li contained in the coating layer is 0.1 to 1.5 atom % with respect to the total number of atoms of Ni, Mn, and Co contained in the composite oxide particles.

Abstract: To provide a gaming table apparatus capable of suppressing the prevention of progress of a game. The gaming table apparatus includes bet units on which gaming media betted by players are placed, a reading unit reading monetary values of the gaming media placed on the bet units, a card shoe in which cards used for a game are accommodated in a drawable manner, a detecting device detecting identification information of the cards taken from the card shoe and outputs the detected identification information, a controller managing the destination to which the game proceeds, a display displaying information about the destination to which the game proceeds managed by the controller, and a memory in which the information displayed on the display is stored, in which the controller determines the destination to which the game proceeds when the monetary values of the gaming medium betted on the bet unit change.

Abstract: An electric vehicle control device includes a first inverter controlling a first group defined by induction motors, and a second inverter controlling a second group defined by induction motors. The first inverter and the induction motors of the first group are connected to each other by a first conductor. The second inverter and the induction motors of the second group are connected by a second conductor. A first length is equal to or less than three times the average value of a second length and a third length. The first length is an inter-center distance between the first conductor and the second conductor, the second length is the maximum length of a conductor portion of the first conductor in the cross section of the first conductor, and the third length is the maximum length of a conductor portion of the second conductor in the cross section of the second conductor.

Abstract: A game controller downloads a chip database at a predetermined timing from a server and stores the chip database as offline data in a storage unit, determines whether communication with the server is possible, when a chip communication unit accesses a game chip, and authenticates the game chip with reference to a offline data table when the communication is impossible.

Abstract: A display device for a vehicle includes: an irradiation unit configured to irradiate a display light for an occupant of the vehicle to display an image; and a storage unit housing the irradiation unit so as to expose a display screen to which the display light is irradiated. The storage unit has an air intake port to take in air and an air discharge port to discharge the air. The display device includes a confluence portion configured to merge a first exhaust air discharged from the air discharge port and a second exhaust air discharged from an air conditioner for a cabin of the vehicle through an air outlet arranged in the cabin. The confluence portion is defined such that a first flow direction of the first exhaust air and a second flow direction of the second exhaust air coincide with each other.

Abstract: The present invention provides a therapeutic agent or a prophylactic agent of dementia containing xanthine oxidase inhibitor such as a compound represented in formula (I), (II), (III) or (IV), or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: A magnetic sensor comprises a magnetic material portion; an excitation portion; and a magnetic detection portion, the magnetic sensor detecting a magnetic field by the magnetic detection portion detecting a detection magnetic field generated due to magnetic moments of the magnetic material portion. The excitation portion is configured to include a conductive material formed into an elongated shape, the magnetic material portion is a soft magnetic film formed on a surface of the conductive material, and the magnetic moments of the magnetic material portion are oriented along circumferential directions of the conductive material orthogonal to a longitudinal direction of the conductive material such that the magnetic moments directed to one of the circumferential directions and the magnetic moments direction in another circumferential direction opposite to the one circumferential direction are distributed in substantially equal amounts.

Abstract: The present invention provides a therapeutic agent or a prophylactic agent of dementia containing xanthine oxidase inhibitor such as a compound represented in formula (I), (II), (III) or (IV), or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: A measurement device includes a sensing portion and a measuring portion. The sensing portion contains at least a fluorescent material whose emitting of fluorescent light ceases due to an action of a radioactive beam. The measuring portion measures a radiation quantity of the radioactive beam, with which the sensing portion is irradiated, based on an amount of decrease in the intensity of the fluorescent light emitted by the fluorescent material contained in the sensing portion when the radioactive beam acts on at least a portion of the fluorescent material. The fluorescent light is emitted due to irradiation of the fluorescent material by an excitation source.

Abstract: A boron neutron capture therapy system has a neutron beam irradiation device, a patient restraint/placement portion, a three-dimensional diagnostic device, an irradiation table, a position adjustment mechanism, and a control unit. The boron neutron capture therapy system performs position determination with a sufficient degree of accuracy at the time of the boron neutron capture therapy. Further, the control unit, using the movement of the irradiation table, performs collision avoidance processing that changes the movement of the irradiation table before the patient restrained on the patient restraint/placement portion receives injury by colliding with the irradiation port, and thus, collision between the patient and the irradiation port can be avoided.

Abstract: A magnetic sensor comprises a magnetic material portion; an excitation portion; and a magnetic detection portion, the magnetic sensor detecting a magnetic field by the magnetic detection portion detecting a detection magnetic field generated due to magnetic moments of the magnetic material portion. The excitation portion is configured to include a conductive material formed into an elongated shape, the magnetic material portion is a soft magnetic film formed on a surface of the conductive material, and the magnetic moments of the magnetic material portion are oriented along circumferential directions of the conductive material orthogonal to a longitudinal direction of the conductive material such that the magnetic moments directed to one of the circumferential directions and the magnetic moments direction in another circumferential direction opposite to the one circumferential direction are distributed in substantially equal amounts.

Abstract: A measurement device includes a sensing portion and a measuring portion. The sensing portion contains at least a fluorescent material whose emitting of fluorescent light ceases due to an action of a radioactive beam. The measuring portion measures a radiation quantity of the radioactive beam, with which the sensing portion is irradiated, based on an amount of decrease in the intensity of the fluorescent light emitted by the fluorescent material contained in the sensing portion when the radioactive beam acts on at least a portion of the fluorescent material. The fluorescent light is emitted due to irradiation of the fluorescent material by an excitation source.

Abstract: A medicament for prophylactic and/or therapeutic treatment of dementia, which comprises a compound represented by the formula (I) having a xanthine oxidase inhibitory action as an active ingredient.

Abstract: Provided is a pilot type solenoid valve (100) providing a good operation even within a wide temperature specification range. The A pilot type solenoid valve (100) is configured such that a main valve body (40) made of aluminum is slidably housed in a suction element (80) made of a magnetic material. Then, an alumite treatment layer is formed on a sliding surface in the main valve body (40) along which the suction element (80) slides by applying an alumite treatment to the sliding surface. Thereby, a linear expansion coefficient of the main valve body (40) is brought close to a linear expansion coefficient of the suction element (80).

Abstract: A boron neutron capture therapy system has a neutron beam irradiation device, a patient restraint/placement portion, a three-dimensional diagnostic device, an irradiation table, a position adjustment mechanism, and a control unit. The boron neutron capture therapy system performs position determination with a sufficient degree of accuracy at the time of the boron neutron capture therapy. Further, the control unit, using the movement of the irradiation table, performs collision avoidance processing that changes the movement of the irradiation table before the patient restrained on the patient restraint/placement portion receives injury by colliding with the irradiation port, and thus, collision between the patient and the irradiation port can be avoided.

Abstract: A medicament for prophylactic and/or therapeutic treatment of dementia, which comprises a compound represented by the formula (I) having a xanthine oxidase inhibitory action as an active ingredient.

Abstract: A method for treating amyotrophic lateral sclerosis is disclosed wherein a compound having xanthine dehydrogenase inhibiting activity is administered.

Abstract: A novel therapeutic agent for amyotrophic lateral sclerosis. A therapeutic agent for amyotrophic lateral sclerosis, including a compound having xanthine dehydrogenase inhibitory action and not acting as a substrate for the purine salvage pathway.